We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+6.7%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$20.1B
AUM Growth
+$2.18B
(+12%)
Cap. Flow
+$1.44B
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
1,701
New
303
Increased
536
Reduced
489
Closed
373
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$260M |
| 2 |
CVS Health
CVS
|
+$204M |
| 3 |
Accenture
ACN
|
+$201M |
| 4 |
Johnson & Johnson
JNJ
|
+$188M |
| 5 |
NVIDIA
NVDA
|
+$168M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$171M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$158M |
| 3 |
CME Group
CME
|
+$128M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$126M |
| 5 |
Apple
AAPL
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.25% |
| 2 | Healthcare | 16.53% |
| 3 | Consumer Discretionary | 13.4% |
| 4 | Industrials | 11.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACH
626
Accendra Health
ACH
$93.1M
| $5.88M | 0.03% |
+404,243
| New | +$7.24M |
|
627
Ovintiv
OVV
$17.5B
| $5.86M | 0.03% |
+162,376
| New | +$7.16M |
|
628
Cable One
CABO
$191M
| $5.85M | 0.03% |
+8,331
| New | +$6.06M |
|
629
Primerica
PRI
$9.57B
| $5.83M | 0.03% |
33,820
+23,232
| +219% | +$3.81M |
|
630
Customers Bancorp
CUBI
$2.8B
| $5.82M | 0.03% |
314,130
+189,357
| +152% | +$5.16M |
|
|
TPH
631
DELISTED
Tri Pointe Homes
TPH
| $5.75M | 0.03% |
227,194
-8,909
| -4% | -$202K |
|
632
Tanger
SKT
$4.42B
| $5.7M | 0.03% |
290,353
+6,387
| +2% | +$119K |
|
|
VISN
633
Vistance Networks Inc
VISN
$2.67B
| $5.69M | 0.03% |
893,786
-499,362
| -36% | -$3.78M |
|
634
Integra LifeSciences
IART
$1.35B
| $5.69M | 0.03% |
99,154
-53,835
| -35% | -$3.03M |
|
635
CareDx
CDNA
$2.45B
| $5.69M | 0.03% |
622,369
+105,536
| +20% | +$1.35M |
|
636
Interparfums
IPAR
$3.78B
| $5.65M | 0.03% |
39,750
+24,299
| +157% | +$2.99M |
|
637
AtriCure
ATRC
$2.22B
| $5.65M | 0.03% |
136,343
+88,209
| +183% | +$3.66M |
|
638
Five Below
FIVE
$13.2B
| $5.64M | 0.03% |
+27,367
| New | +$5.39M |
|
639
BioCryst Pharmaceuticals
BCRX
$2.71B
| $5.62M | 0.03% |
673,265
+408,048
| +154% | +$3.93M |
|
|
CBAY
640
DELISTED
Cymabay Therapeutics
CBAY
| $5.61M | 0.03% |
+643,812
| New | +$5.15M |
|
641
Phillips Edison & Co
PECO
$5.17B
| $5.6M | 0.03% |
171,653
+45,303
| +36% | +$1.48M |
|
642
Blackstone Mortgage Trust
BXMT
$2.41B
| $5.57M | 0.03% |
312,165
+58,422
| +23% | +$1.25M |
|
643
Q2 Holdings
QTWO
$3.9B
| $5.52M | 0.03% |
+224,336
| New | +$6.67M |
|
644
Wingstop
WING
$3.05B
| $5.52M | 0.03% |
30,070
-1,334
| -4% | -$219K |
|
645
LiveRamp
RAMP
$2.3B
| $5.5M | 0.03% |
250,633
+21,943
| +10% | +$523K |
|
646
Community Bank
CBU
$3.43B
| $5.48M | 0.03% |
104,459
+26,285
| +34% | +$1.54M |
|
647
Lennox International
LII
$14.5B
| $5.39M | 0.03% |
21,465
+15,648
| +269% | +$3.95M |
|
648
Las Vegas Sands
LVS
$29.6B
| $5.33M | 0.03% |
+92,776
| New | +$5.19M |
|
|
RVNC
649
DELISTED
Revance Therapeutics, Inc.
RVNC
| $5.32M | 0.03% |
165,026
-94,427
| -36% | -$2.94M |
|
650
Verisk Analytics
VRSK
$23.5B
| $5.29M | 0.03% |
+27,572
| New | +$4.99M |
|
Similar funds
VAI
Voloridge Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, Voloridge Investment Management held 1,701 positions worth $20.1B, up 12% from $17.9B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Voloridge Investment Management deployed $1.44B of net new capital in Q1 2023, opening 303 new positions and adding to 536 existing holdings. Its largest new stake was NVIDIA: 7,755,630 shares worth $215M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $158M trimmed.
- Voloridge Investment Management's largest Q1 2023 buy was NVIDIA: 7,755,630 shares worth $215M.
- Voloridge Investment Management added most to UnitedHealth in Q1 2023, an estimated $260M increase.
- Voloridge Investment Management's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $158M.
- Voloridge Investment Management fully exited Meta Platforms (Facebook) in Q1 2023, selling an estimated $171M.
- Voloridge Investment Management's ten largest holdings make up 9.1% of its $20.1B portfolio in Q1 2023.
- Voloridge Investment Management opened 303 new positions and closed 373 in Q1 2023.
- Voloridge Investment Management's portfolio value rose 12% quarter-over-quarter to $20.1B.
Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.